The company, which is an artificial intelligence software platform focused on heart disease, sold 16.67 million shares at $19 each, according to a
The Mountain View, California-based company had boosted the size and price range of the IPO to 16.67 million shares for $17 to $18 apiece, up from 12.5 million shares at $15 to $17 each, according to its filings with the US Securities and Exchange Commission.
At the IPO price, Heartflow would have a market value of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.